![Leonard W. Seymour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leonard W. Seymour
President chez
British Society for Gene & Stem Cell Therapy
Profil
Leonard W.
Seymour is the founder of Hybrid BioSystems Ltd. which was founded in 2001.
He held the title of Director in 2010.
Currently, he is the Head-Clinical Pharmacology at the University of Oxford and the President of the British Society for Gene & Stem Cell Therapy.
Postes actifs de Leonard W. Seymour
| Sociétés | Poste | Début |
|---|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 04/12/2009 |
British Society for Gene & Stem Cell Therapy | President | 04/12/2009 |
Anciens postes connus de Leonard W. Seymour
| Sociétés | Poste | Fin |
|---|---|---|
Hybrid BioSystems Ltd.
 Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Fondateur | 15/12/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Commercial Services |
British Society for Gene & Stem Cell Therapy |
